Ken Fisher acquired 17.9 Thousand Sarepta Therapeutics shares worth $654 Thousand. That's 0.00% of their equity portfolio (696th largest holding). The first Sarepta Therapeutics trade was made in Q3 2017. Since then Ken Fisher bought shares thirteen more times and sold shares on fifteen occasions. The investor's estimated purchase price is $1.29 Million, resulting in a loss of 49%.